TAP Block Versus Local Anesthesia Wound Infiltration for Postoperative Pain Relief After Appendicectomy in Children (PABLO)

TAP Block Versus Local Anesthesia Infiltration at Wound Site for Postoperative Pain Relief After Laparoscopic Appendicectomy in Children

When performing laparoscopic appendectomy in children, regional anesthetic techniques are rou-tinely used concomitantly with general anesthesia. These techniques include local infiltration of the trocar wounds or transverse abdominal plane block (TAP block). In 2018, a position paper of the European Society of Pediatric Anaesthesiology advised for TAP block over local infiltration of the trocar wounds. However, there is no randomized study comparing both techniques in children. The aim of this study is to compare morphine consumption during the first 24 postoperative hours in children undergoing laparoscopic appendectomy and randomly allocated to either local infiltration of the trocar wounds or TAP block.

Study Overview

Status

Recruiting

Detailed Description

This is a double blind randomized study with two parallel groups. Children between 3 and 15 years of age with indication of laparoscopic appendectomy will be approached for inclusion in this trial. Informed consent will be asked for from the parents and the child. Before surgery, patients will be randomized to either local infiltration of the trocar wounds or TAP block using sequentially numbered sealed envelope each with a random number inside. Patients with peritonitis will be excluded. A standardized analgesia protocol within the first 24 post-operative hours will be applied and the primary outcome is nalbuphine consumption during this time frame. Secondary outcomes include postoperative pain (FLACC assessment tool) and postoperative nausea and vomiting.

Study Type

Interventional

Enrollment (Anticipated)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Besançon, France, 25000
        • Recruiting
        • CHU Besançon
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age betwween 3 and 15 years
  • Weight < or = 50 kg
  • indicaction of coelioscopic appendicectomy
  • ASA 1,2 or 3
  • consent of the children and the holder of parental autority

Exclusion Criteria:

  • Age<3 years or > 15years or weight > 50kg
  • refusal of the children and the holder of parental autority
  • ASA 4
  • Peritonitis
  • Patients with long term morphinic traitment
  • Epilepsy
  • Hepato-cellular insuffisiancy
  • local anesthesia allergy or nalbuphine allergy
  • coagulation abnomrmality
  • exclusion of health insurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: TAP Block

Transverse abdominal block is realisated at the beginning of the surgery with ultrasound guided technique with levobupivacaine 2.5mg/mL, 0.3mL/kg each side.

The patient receives usual analgesia protocol.

To compare TAP block versus local infiltration of the trocar wounds with levobupivacaine 2.5 mg/ml for post operative pain relief after laparoscopic appendicectomy in children
Active Comparator: local infiltration of the trocar wounds

local infiltration of the trocar wounds is realisated at the end of the surgery by the surgeon with levobupivacaine 2.5mg/mL 0.6mL/kg distributed in each trocar opening.

The patient receives usual analgesia protocol.

To compare TAP block versus local infiltration of the trocar wounds with levobupivacaine 2.5 mg/ml for post operative pain relief after laparoscopic appendicectomy in children

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cumulative dose of nalbuphine in the 24 first hours post surgery
Time Frame: 24 hours
recording in mg/kg
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cumulative dose of nalbuphine H0-H12 post surgery
Time Frame: from beginning to 12th hour
recording in mg/kg
from beginning to 12th hour
cumulative dose of nalbuphine H13-H24 post surgery
Time Frame: From 13th hour to 24th hour
recording in mg/kg
From 13th hour to 24th hour
FLACC analgesia score at H1 H2 H6 H12 H24
Time Frame: FLACC score will be performed from awakenig to 24 hours post surgery
Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
FLACC score will be performed from awakenig to 24 hours post surgery
FLACC score mean
Time Frame: FLACC score will be performed from awakenig to 24 hours surgery
Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
FLACC score will be performed from awakenig to 24 hours surgery
individual variations of FLACC score
Time Frame: FLACC score will be performed from awakenig to 24 hours surgery
Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
FLACC score will be performed from awakenig to 24 hours surgery
timing of first injection of nalbuphine
Time Frame: in the first 24 post operative hours
recording date and time of first injection
in the first 24 post operative hours
incidence of post operative nausea and vomiting
Time Frame: in the first 24 post operative hours
recording the incidence post operative nausea and vomiting
in the first 24 post operative hours
timing of first standing up
Time Frame: in the first 24 post operative hours
recording date and time of first standing up
in the first 24 post operative hours
adverse events
Time Frame: in the first 24 post operative hours
adverse event monitoring
in the first 24 post operative hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2021

Primary Completion (Anticipated)

December 25, 2023

Study Completion (Anticipated)

May 25, 2024

Study Registration Dates

First Submitted

June 18, 2021

First Submitted That Met QC Criteria

July 9, 2021

First Posted (Actual)

July 20, 2021

Study Record Updates

Last Update Posted (Actual)

March 30, 2023

Last Update Submitted That Met QC Criteria

March 29, 2023

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on Levobupivacaine Hydrochloride 2.5 MG/ML

3
Subscribe